FDA Inspection 1050206 — Helsinn Therapeautics Inc.

Helsinn Therapeautics Inc. — FEI 3011080141

The FDA completed an inspection of Helsinn Therapeautics Inc. on Feb 9, 2018 in Iselin, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 9, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Iselin, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.